Glossary
Supplementary Protection Certificate (SPC)
Last updated 13 May 2008
Description
SPCs, which were introduced by European legislation, may be granted to extend the period of protection under a patent in respect of a specified pharmaceutical (or plant protection) product that is protected by the patent.
The intention is to compensate the patentee for at least some of the period of patent term that has expired after patent filing while it undergoes the lengthy process of getting its product authorised and on the market.
The protection granted under an SPC commences on expiry of the basic patent. Its duration is the period equal to the time lost between the date of patent filing and first marketing approval anywhere in the Community, minus five years, to a maximum of five years’ extension.
SPCs (in the present context) are governed by Council Regulation (EEC) 1768/92 (‘the Regulation’). Under Article 3(a) of the Regulation, ‘a certificate shall be granted if, in the Member State in which the application … is submitted … the product is protected by a patent in force’.
‘Product’ is defined in Article 1(b) as ‘the active ingredient or combination of active ingredients of a medicinal product’.
In order to obtain the grant of a certificate, the product to which the application relates must meet the conditions laid down in the Regulation.
Examples
See article: Extension Denied: Gilead Sciences' SPC Application for Combination Anti-Retrovirals.
See Also
None.
Deal term reports
The information you provide is excellent and we look forward to doing more business with you in the future
...You have published very timely and interesting materials.... I am excited.... It is an excellent publication and pretty well up to date...
CurrentPartnering Reports
The latest reports on best practise for dealmakers available from CurrentPartnering
Quick links
Contribute
CurrentPartnering is always seeking new contributions or updates to the glossary. Contact us now.